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 Prominent data indicate that flunarizine (flu), a calcium channel blocker, has 
neuroprotective effect. However, several authors have reported that the chronic use of flu 
can produce drug-induced Parkinsonism. Previously, we showed that B vitamins 
supplement (B com) has antiparkinsonian effect. In the present study, we evaluated the 
effect of pretreatment with flu and a combination of flu and B com on the 6-
hydroxydopamine (6-OHDA) - induced Parkinsonism.  
 6-OHDA (4 μl, 4 μg/μl) was injected into right striatum by stereotaxic surgery. 
Different groups of rats received flu (5 or 10 mg/kg) or B com or a combination of them 
before the toxin to three weeks after that. The severity of Parkinsonism was assessed by 
conventional behavioral tests and also biochemical measurement of striatal dopamine level. 
Furthermore, malondialdehyde (MDA) concentration was measured in the serum and brain 
suspension. 
 Pretreatments with flu or B com significantly attenuated apomorphine- induced 
rotations and improved rotarod performance, but they had little effect on the 6- OHDA- 
induced swinging behavior. The pretreatments also reduced the decreasing effect of 6- 
OHDA on the striatal dopamine level. These antiparkinsonian effects were potentiated when 
animals were pretreated with a combination of flu and B com. In addition, B com alone or in 
combination with flu reduced MDA concentration especially in the brain tissue. On the 
other hand, flu increased MDA concentration in the serum.  
 Our data show that co-administration of B com with flu potentiate largely the 
antiparkinsonian effect and may attenuate its adverse effects.  
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